Sun Pharma has acquired Pola Pharma, a Japanese pharmaceutical company involved in research and development, manufacture, sale and distribution of branded and generic products in Japan. The portfolio of Pola Pharma primarily comprises dermatology products.   Pola Pharma, part of Pola Orbis Group, has two manufacturing facilities in Saitama with capabilities to manufacture topical products and injectables. It also has R&D capabilities to develop new technologies and formulations.   “This ...